1. Home
  2. JOUT vs IMMP Comparison

JOUT vs IMMP Comparison

Compare JOUT & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JOUT

Johnson Outdoors Inc.

HOLD

Current Price

$44.87

Market Cap

450.6M

ML Signal

HOLD

Logo Immutep Limited

IMMP

Immutep Limited

HOLD

Current Price

$2.93

Market Cap

426.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JOUT
IMMP
Founded
1970
1987
Country
United States
Australia
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
450.6M
426.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
JOUT
IMMP
Price
$44.87
$2.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
50.4K
287.8K
Earning Date
02-02-2026
02-26-2026
Dividend Yield
2.95%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$592,415,000.00
$3,306,742.00
Revenue This Year
$8.66
$292.48
Revenue Next Year
$5.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
31.28
52 Week Low
$21.33
$1.32
52 Week High
$48.50
$3.53

Technical Indicators

Market Signals
Indicator
JOUT
IMMP
Relative Strength Index (RSI) 59.60 58.03
Support Level $42.37 $2.91
Resistance Level $45.93 $3.16
Average True Range (ATR) 1.45 0.15
MACD -0.02 -0.03
Stochastic Oscillator 86.05 41.67

Price Performance

Historical Comparison
JOUT
IMMP

About JOUT Johnson Outdoors Inc.

Johnson Outdoors Inc is a manufacturer and marketer of branded seasonal, outdoor recreation products used for fishing from a boat, diving, paddling, hiking and camping. The company has four operating segment: Fishing, Camping, Watercraft Recreation, and Diving. It generates maximum revenue from the Fishing segment which produces and markets products under different brands such as Minn Kota electric motors for quiet trolling or primary propulsion, marine battery chargers and shallow water anchors; Humminbird sonar and GPS equipment for fish finding, navigation and marine cartography; and Cannon downriggers for controlled-depth fishing. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe, Canada, and other regions.

About IMMP Immutep Limited

Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-004, TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

Share on Social Networks: